Horizon Pharma PLC Financials
Based on the key measurements obtained from Horizon Pharma's financial statements, Horizon Pharma PLC is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
Horizon |
Understanding current and past Horizon Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Horizon Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Horizon Pharma's assets may result in an increase in income on the income statement.
Horizon Pharma Stock Summary
Horizon Pharma competes with Bristol Myers, AbbVie, Merck, Gilead Sciences, and Johnson Johnson. Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois Chicago, Illinois Lake Forest, Illinois South San Francisco, California Washington, D.C. Gaithersburg, Maryland Rockville, Maryland and Mannheim, Germany. Horizon Therapeutics is traded on NASDAQ Exchange in the United States.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | IE00BQPVQZ61 |
Business Address | 70 St Stephens |
Sector | Pharmaceuticals |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.horizontherapeutics.com |
Phone | 353 1 772 2100 |
Currency | USD - US Dollar |
Horizon Pharma Key Financial Ratios
Return On Equity | 0.0854 | |||
Return On Asset | 0.0444 | |||
Target Price | 116.5 | |||
Beta | 1.01 | |||
Z Score | 7.48 |
Horizon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Horizon Pharma's current stock value. Our valuation model uses many indicators to compare Horizon Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Horizon Pharma competition to find correlations between indicators driving Horizon Pharma's intrinsic value. More Info.Horizon Pharma PLC is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Horizon Pharma PLC is roughly 1.92 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Horizon Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Horizon Stock
If you are still planning to invest in Horizon Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Horizon Pharma's history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |